Donate

Media center

At PATH, our global health experts are developing partnerships, new devices, and solutions to the world's most pressing health needs. Contact us to speak with one of PATH's experts today.

Contact Us

Director of Global Strategic Communications:
Lindsay Bosslet, MPH

Phone: 206.285.3500

Fax: 206.285.6619

Email: media@path.org

PATH is advancing health equity around the world

January 30, 2024
How does human milk banking help ensure child health?
November 20, 2023
In Kenya, Beatrice Oyugi is helping children reach their full potential
March 8, 2024
Celebrating women in the fight to end malaria

Stay informed and make a difference: Subscribe to PATH Insights for a fairer and healthier future

Featured Press Coverage

October 30, 2022
A pandemic silver lining in Senegal
The Atlantic
November 14, 2023
Opinion: Collaborative solutions key to advance universal health coverage
Devex
January 7, 2023
How India has emerged as a global leader in public health
Hindustan Times

Recent Press Coverage

  1. Impact of public debt and low tax revenues on health and immunisation
    PATH’s Esther Nasikye speaks with Newzroom Afrika about the need for increased domestic financing for immunization and health programs in African countries.
    Published: February 2024
  2. Could new vaccines end malaria in Africa?
    After decades of research and development by PATH, GlaxoSmithKline, and other partners, the first doses of the RTS,S malaria vaccine began reaching children in Cameroon earlier this year.
    Published: February 2024
  3. Good intentions, bad outcomes: The dangers of donated medical devices
    COVID-19 spurred an increase in gifted medical devices, but the donations have left some facilities in under-resourced countries overwhelmed. PATH experts explain how too many facilities often lack training to use the equipment or funding to maintain it.
    Published: February 2024
  4. WHO grants prequalification to innovative polio vaccine, nOPV2, as nearly 1 billion doses are administered
    The World Health Organization granted prequalification to the novel oral polio vaccine type 2 (nOPV2), an innovative vaccine developed by a consortium of experts including PATH.
    Published: January 2024
Next

We develop evidence-based expertise and resources

Our global team leverages data and evidence to develop resources and innovations that bring good health to more people.

Explore our evidence

Join the latest discussions on health equity.

We partner with the public and private sector, government, and academia from around the world to share insightful conversations on the latest topics affecting health equity.

Explore PATH events

PATH Newsroom

954 Item s
954 Item s
    Date
    From
    To
  1. Remembering Kent Campbell
    The creator and first director of PATH MACEPA leaves an indelible mark on PATH and the malaria community.
    Published: February 2024
    Statement
  2. Uganda's first-ever veterinary laboratories receive recommendation for international accreditation
    Published: February 2024
    Press Release
  3. PATH and the Conrad N. Hilton Foundation partner to promote child development services in facilities and communities
    Published: February 2024
    Press Release
  4. PATH statement on the continuing violence in Israel, Gaza, and the West Bank
    Published: February 2024
    Statement
  5. PATH congratulates Thailand on granting conditional approval for emergency use to first locally produced COVID-19 vaccine
    The NDV-HXP-S COVID-19 vaccine produced by Thailand’s Government Pharmaceutical Organization (GPO) has the potential to be an affordable option that advances vaccine supply sustainability and pandemic preparedness.
    Published: January 2024
    Statement
Previous
Next